Sloan Kettering Gets Trimmed Fees In IP Fight
A New York federal judge ordered Errant Gene Therapeutics LLC to pay the Sloan Kettering Institute for Cancer Research $88,339 in attorneys' fees Tuesday after the biopharmaceutical company was sanctioned for...To view the full article, register now.
Already a subscriber? Click here to view full article